Nasal Cannula Market Report 2026

The nasal cannula market size has grown strongly in recent years. It will grow from $9.79 billion in 2025 to $10.73 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing prevalence of respiratory diseases, adoption of low-flow oxygen therapies, rise in hospital admissions for copd, use of nasal cannulas in emergency care, limited availability of advanced oxygen delivery devices.

The nasal cannula market size is expected to see strong growth in the next few years. It will grow to $15.31 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for home oxygen therapy, growth in high-flow nasal cannula adoption, rising investments in respiratory care innovation, expanding use in long-term care facilities, development of advanced ergonomic cannula designs. Major trends in the forecast period include increasing adoption of high-flow nasal cannula therapy, rising demand for disposable oxygen delivery devices, growing use of nasal cannulas in home healthcare settings, expanding pediatric and neonatal respiratory support solutions, advancements in soft, skin-friendly cannula materials.

The rising prevalence of respiratory diseases is driving growth in the nasal cannula market. Respiratory diseases, which affect the lungs and airways, impair breathing and oxygen exchange. Factors such as air pollution, smoking, viral infections, and increased exposure to allergens are contributing to this rise. Nasal cannulas are used to deliver supplemental oxygen directly into the nostrils, helping patients with breathing difficulties maintain adequate oxygen levels. For instance, in June 2025, according to the Office for Health Improvement and Disparities (OHID), a UK-based government department, emergency admissions for respiratory disease in England increased by 7% from the financial year ending 2023 to the financial year ending 2024. Therefore, the increasing number of respiratory diseases is boosting the nasal cannula market.

Major companies in the nasal cannula market are focusing on innovations such as low-flow nasal cannulas to enhance patient comfort, improve oxygen delivery efficiency, and meet specific clinical needs. Low-flow nasal cannulas deliver supplemental oxygen at flow rates typically ranging from 1 to 6 liters per minute through two prongs inserted into the nostrils. For instance, in May 2024, CNSAC MedShop, a Germany-based diagnostics and consumables company, launched NasalOxy, a patented low-flow nasal cannula designed to improve comfort and effectiveness for long-term oxygen therapy. Its advanced design reduces contact with mucous membranes, minimizing irritation and discomfort while supporting both nasal and oral breathing.

In May 2023, Flexicare, a UK-based provider of respiratory care devices, acquired Clement Clarke International for an undisclosed amount. This acquisition strengthens Flexicare’s global respiratory care portfolio by expanding its diagnostic and monitoring capabilities and enhancing its position in the management and treatment of respiratory conditions. Clement Clarke International is a UK-based provider of respiratory diagnostic devices, inhaler training tools, and peak flow meters used for asthma and other respiratory disorders.

Major companies operating in the nasal cannula market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company, ResMed Inc., Teleflex Incorporated, Angiplast Pvt. Ltd., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Well Lead Medical Co. Ltd., GaleMed Corp., Vapotherm Inc., Salter Labs Inc., Dynarex Corporation, Mais India Medical Devices Pvt. Ltd., Allied Medical LLC, Besmed Health Business Corp., Flexicare Medical Ltd., Medin Medical Innovations AB, Airways Surgical Pvt. Ltd., Great Group Medical Co. Ltd., HUM GmbH.

North America was the largest region in the nasal cannula market in 2025. The regions covered in the nasal cannula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nasal cannula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the nasal cannula market by increasing the cost of imported plastics, silicone materials, and manufacturing equipment used in low-flow and high-flow cannula production. Hospitals and long-term care centers in North America and Europe are most impacted due to reliance on Asian manufacturing hubs. These added costs have raised procurement prices for respiratory devices. However, tariffs are accelerating local manufacturing of medical disposables, improving supply chain security.

The nasal cannula market research report is one of a series of new reports that provides nasal cannula market statistics, including nasal cannula industry global market size, regional shares, competitors with a nasal cannula market share, detailed nasal cannula market segments, market trends and opportunities, and any further data you may need to thrive in the nasal cannula industry. This nasal cannula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A nasal cannula is a medical device designed to deliver supplemental oxygen to patients in need of respiratory support. It features two small prongs that fit into the nostrils, connected by a thin tube to an oxygen source, allowing for continuous and comfortable oxygen delivery while enabling the patient to speak and eat.

The main types of nasal cannula include low-flow and high-flow nasal cannulas. A low-flow nasal cannula delivers a small, controlled amount of oxygen through the nostrils to assist patients with breathing difficulties. It is typically made from materials such as plastic or silicone and comes in various sizes for neonates, infants, children, and adults. Different prong designs, including straight, curved, flared, and other variations, are available. Nasal cannulas are used by end users such as hospitals, ambulatory healthcare services, long-term care centers, and other healthcare facilities.

The nasal cannula market consists of sales of standard nasal cannulas, pediatric nasal cannulas, disposable nasal cannulas, and reusable nasal cannulas. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.